FDA CDER and CBER & Duke-Margolis Center for Health Policy | Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Diseas

[FDA]

The purpose of this public workshop is to discuss topics relevant to the development of endpoints for rare diseases.


Baca selengkapnya di : http://www.fda.gov...